The event listed below is a non-CME Programs wholly sponsored and supported by the commercial entity listed. By holding the Programs, the commercial entitiy has represented that the Programs have been developed and will be implemented in accordance with the requirements of the FDA and applicable standards of the PhRMA Code on Interactions with Healthcare Professionals. The commercial entity is to observe all guidelines established by federal and state regulatory agencies regarding non-CME educational or promotional presentations throughout the duration of the Program. The content and views expressed during the Program are those of the commercial entity and presenters. The ACR by making this venue available does not guarantee, warrant or endorse the content of the Program nor the products discussed and reviewed during the Program.
Developed and offered by Abbott
Upon completion of this session, participants should be able to:
- review the current evidence for treating patients to a therapeutic target
- understand available tools to measure disease activity in patients with rheumatoid arthritis
- discuss emerging clinical trial designs and application to everyday patient care
- review clinical evidence regarding care of patients with early moderate to severe rheumatoid arthritis
To see other sessions for this day, use the date buttons to the left.